SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. – KDNY

NEW YORK, July 19, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. (“Chinook” or the “Company”) (NASDAQ: KDNY).   Such investors are advised to contact Robert S. Willoughby at  newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Chinook and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

Full story available on Benzinga.com

Read More

Tags

Share this post:

JOIN THE HYVE

Gain insights, receive dynamic opportunities directly to your inbox. Sign up now…